NEW YORK (360Dx) – Roche today announced the cobas m 511 dedicated hematology testing solution has received CE marking, allowing it to be marketed in countries that recognize the designation. 

Roche is launching the integrated hematology analyzer, marking Roche Diagnostics' entry into the hematology market. 

According to the company, current hematology testing requires larger blood samples from patients, which then need to be run across several different systems. As a result, testing is labor and time intensive and can provide inconsistent results. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.